Company Analysis Select Medical Holdings Corporation
1. Summary
Advantages
- Dividends (2.16%) are higher than the sector average (1.29%).
- The stock's return over the last year (28.45%) is higher than the sector average (-15.65%).
- Current debt level 51.16% is below 100% and has decreased over 5 years from 61.44%.
- The company's current efficiency (ROE=18.9%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (18.27 $) is higher than fair price (17.15 $)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Select Medical Holdings Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.8% | -13.6% | 2.8% |
| 90 days | 0.1% | -21.4% | 2.7% |
| 1 year | 28.5% | -15.7% | 26% |
SEM vs Sector: Select Medical Holdings Corporation has outperformed the "Healthcare" sector by 44.11% over the past year.
SEM vs Market: Select Medical Holdings Corporation has outperformed the market by 2.46% over the past year.
Stable price: SEM is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SEM with weekly volatility of 0.5472% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (18.27 $) is higher than the fair price (17.15 $).
Price is higher than fair: The current price (18.27 $) is 6.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (12.25) is lower than that of the sector as a whole (57.86).
P/E vs Market: The company's P/E (12.25) is lower than that of the market as a whole (47.62).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.89) is lower than that of the sector as a whole (9.39).
P/BV vs Market: The company's P/BV (1.89) is lower than that of the market as a whole (22.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.4474) is lower than that of the sector as a whole (4.06).
P/S vs Market: The company's P/S indicator (0.4474) is lower than that of the market as a whole (15.2).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (9.77) is lower than that of the sector as a whole (17.55).
EV/Ebitda vs Market: The company's EV/Ebitda (9.77) is lower than that of the market as a whole (19.68).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -1.2% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-1.2%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-66.62%).
5.4. ROE
ROE vs Sector: The company's ROE (18.9%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (18.9%) is higher than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (3.17%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (3.17%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.46%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (7.46%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.16% is higher than the average for the sector '1.29%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.16% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 2.16% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (26.24%) are at a comfortable level.
8. Insider trades
8.1. Insider trading
Insider Selling More insider purchases by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 26.11.2024 | TAVENNER MARILYN B Director |
Sale | 21.09 | 674 880 | 32 000 |
| 26.11.2024 | ORTENZIO ROBERT A EXECUTIVE CHAIRMAN |
Sale | 19.55 | 74 383 900 | 3 804 805 |
| 08.04.2024 | ORTENZIO ROBERT A EXECUTIVE CHAIRMAN |
Sale | 29.9 | 1 495 000 | 50 000 |
| 08.09.2023 | ORTENZIO ROBERT A EXECUTIVE CHAIRMAN |
Sale | 26.82 | 1 341 000 | 50 000 |
| 29.06.2023 | ORTENZIO ROBERT A EXECUTIVE CHAIRMAN |
Sale | 32 | 3 200 000 | 100 000 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
